Image: InvestorideasBiotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance
• Biotech companies including Soligenix, Moderna, Regeneron, and Aethlon Medical are accelerating the development of vaccines and therapeutics to combat a global outbreak of Bundibugyo ebolavirus in 2026. • Regeneron's maftivimab, a potent antibody found in the FDA-approved Inmazeb, has been recommended by the WHO's Therapeutics Advisory Group for use in clinical trials. • Aethlon Medical (Nasdaq:AEMD) is preparing to coordinate with global health authorities to deploy its Hemopurifier device as part of the medical response.
investorideas.com

